ALEXANDRA JONES: Open Payments
NPI 1245750371 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 38 payments from 14 companies in 2025. Trend: 2023 $320 · 2024 $247 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $179 |
| Novo Nordisk Inc | 4 | $78 |
| Amgen Inc. | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Lundbeck LLC | 3 | $58 |
| Xeris Pharmaceuticals, Inc. | 3 | $55 |
| Paratek Pharmaceuticals, Inc. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Dexcom, Inc. | 1 | $23 |
| Pharmacosmos Therapeutics Inc. | 1 | $22 |
Products named: REXULTI, VRAYLAR, KEVEYIS, OTEZLA, MAVYRET, NUZYRA, Dexcom G6 Transmitter, Ozempic.
Industry payments across KS — which companies pay providers there.
